Kodiak Sciences (KOD)
(Delayed Data from NSDQ)
$2.64 USD
+0.06 (2.33%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $2.63 -0.01 (-0.38%) 7:30 PM ET
3-Hold of 5 3
D Value A Growth C Momentum C VGM
Income Statements
Fiscal Year end for Kodiak Sciences Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 0 | 0 | 0 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 0 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 277 | 341 | 267 | 136 | 49 |
Income After Depreciation & Amortization | -277 | -341 | -267 | -136 | -49 |
Non-Operating Income | 17 | 8 | 0 | 3 | 2 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -260 | -334 | -267 | -133 | -47 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -260 | -334 | -267 | -133 | -47 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -260 | -334 | -267 | -133 | -47 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -252 | -331 | -258 | -132 | -49 |
Depreciation & Amortization (Cash Flow) | 25 | 10 | 9 | 4 | 1 |
Income After Depreciation & Amortization | -277 | -341 | -267 | -136 | -49 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 52.41 | 52.25 | 51.79 | 45.74 | 37.85 |
Diluted EPS Before Non-Recurring Items | -4.97 | -6.39 | -5.16 | -2.91 | -1.25 |
Diluted Net EPS (GAAP) | -4.97 | -6.39 | -5.16 | -2.91 | -1.25 |
Fiscal Year end for Kodiak Sciences Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost Of Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 47.98 | 46.05 | 63.38 | 54.50 | 84.83 |
Income After SG&A, R&D, and Dept/Amort Expenses | -47.98 | -46.05 | -63.38 | -54.50 | -84.83 |
Non-Operating Income | 2.87 | 3.02 | 3.86 | 4.50 | 4.65 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
Pretax Income | -45.12 | -43.04 | -59.52 | -50.01 | -80.19 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -45.12 | -43.04 | -59.52 | -50.01 | -80.19 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -45.12 | -43.04 | -59.52 | -50.01 | -80.19 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 52.55 | 52.51 | 52.48 | 52.46 | 52.38 |
Diluted EPS Before Non-Recurring Items | -0.86 | -0.82 | -1.13 | -0.95 | -1.53 |
Diluted Net EPS (GAAP) | -0.86 | -0.82 | -1.14 | -0.95 | -1.53 |